Several data mining methods have been applied to explore biological data and understand the mechanisms that regulate genetic and metabolic diseases. The underlying hypothesis is that the identification of signatures can help the clinical identification of diseased tissues. Under this principle many different methodologies have been tested mostly using unsupervised methods. A common trend consists in combining the information obtained from gene expression and protein-protein interaction networks analyses or, more recently, building series of complex networks to model system dynamics. Despite the positive results that these works present, they typically fail to generalize out of sample datasets. In this paper we describe a supervised classification approach, with a new methodology for extracting the network topology dynamics embedded in a disease system, to improve the capacity of cancer prediction, using exclusively the topological properties of biological networks as features. Four microarrays datasets were used, for testing and validation, three from breast cancer experiments and one from a liver cancer experiment. The obtained results corroborate the potential of the proposed methodology to predict a certain type of cancer and the necessity of applying different classification models to different types of cancer.
INTRODUCTION
Cancer is a complex genetic disease that affects an increasing number of citizens all over the world. In 2015, more than 1.6 million new cancer cases are expected in the United States, from which around 15% correspond to breast cancer (Siegel et al., 2015) . Understanding the underlying biological mechanisms behind this disease has been the goal of many and continuous research initiatives.
One strategy to study cancer is using microarrays, a high-throughput technology that measures gene expression, allowing the parallel analysis of genes in several samples. Different individuals or different conditions (healthy and non-healthy cells of the same individual) originate distinct microarray samples with gene expression values. These different samples can reveal signatures that help to distinguish cancer from non-cancer tissues.
In a network-based approach, bio-entities such as genes and proteins can be represented as nodes and their relationships as edges. Using this approach we can model biological processes that can be analysed using graph and network methods. The construction of network-based models to study complex phenomena, like cancer diseases, allows the capture of the embedded systems dynamics. This dynamics can be captured by constructing series of different complex networks through time, through different stages and through different traits. The study of the topological properties of these complex networks allows understanding specific structures, signatures and similarities. This paper presents a methodology to construct protein-protein interaction networks to capture the existent system dynamics beneath their topology. These networks, here named Sample-Series Networks (SSN), are constructed using a group of cancer and healthy microarray samples. Information features are exclusively obtained through the analysis of the topological properties of these networks and without any other biological information. Using the obtained set of topological features a supervised approach is then used to classify between cancer and non-cancer tissues samples. This work aims to address several questions, namely: are there evidences of signatures beneath the SSN that allow us to classify samples as cancer or non-cancer? Which topological measures give better results as classification features among the several groups considered? Does a classification model distinguish different types of cancers?
Tests have been made in four gene expression microarray experiments, three from breast cancer and one from liver cancer.
BACKGROUND
Anomalies in a gene, protein or other bio-entity can cause diseases and since the arrival of the nextgeneration sequencing (NGS), that are found more evidences of human genes being correlated to diseases. Data from November 6 th , 2015 obtained in the Online Mendelian Inheritance in Man database (OMIM) (Amberger et al., 2015) shows that there are 5597 phenotypes for which the molecular basis is known and 3453 genes with phenotype-causing mutation. Most disease genes are not essential, being essential genes typically organized as hubs in a complex network (Barabási et al., 2011, Jonsson and Bates, 2006) .
Biological networks are not random, they have clustered groups of bio-entities, like genes or proteins. They are also sparsely connected, which is considered an evolutionary advantage for preserving robustness to random failures (Barabasi and Oltvai, 2004) . Also, it is known that genes and proteins that are involved in the same phenotype are network neighbours (Oti et al., 2006) and that a disease phenotype can be associated to interactions in a biological complex network that models these biological processes (Menche et al., 2015) .The comparison of networks can use global and local topological measures. Both are used in (Pržulj et al., 2004) to show that the structure of yeast PPI networks is closer to the geometric random graph model relatively to graphlet frequency. In (Pržulj, 2007) a new network similarity measure is defined based on the graphlet degree distribution as a generalization of the degree distribution.
Genomic changes that are translated to proteins can alter biological functions and a system-based approach modelled through complex networks can assist the discovery of signatures related to disease mechanisms, by analysing their topology (Vidal et al., 2011 , Barabási et al., 2011 , Arrais and Oliveira, 2011 , Farkas et al., 2011 .
Cliques help to understand the mechanisms involved in cancer, since they are fully connected subnetworks more conserved in biological networks. In cliques, genes are functionally related and highly expressed. In (Pradhan et al., 2012) it is proposed a topological and biological feature-based network approach, integrating the expression data, along with network topological information and biological information. Cliques are scored based on these information and are considered as gene signatures for the colorectal cancer (CRC).
Sets of biological complex networks can be constructed across multiple conditions, like species, time, and evolutionary states, traits or even samples, as the novel approach used in this paper, building dynamic models of the studied system.
A systems biology approach can be used to interpret biological data. The (Trapé and GonzalezAngulo, 2012 ) review addresses the contributions of systems biology. DNA, RNA and protein changes data are integrated to understand breast cancer metastasis process. (Sonachalam et al., 2012) shows how to build a PPI network representative of the colorectal cancer (CRC) where nodes are genes/proteins obtained from Gene Set Enrichment Analysis (GSEA). (Barter et al., 2014) compares single-gene, gene-set and two PPI network-based methods, using gene expression microarrays data, applied to melanoma and ovarian cancer. In singlegene, features are the expression values of informative genes identified via differential expression analysis. In the gene-set method, genes are grouped into sets using biological knowledge, which are used as features for classification. In the first network-based method features are the most informative individual genes selected using the PPI network, while in the second network-based method, features are identified or are extracted from them considering the edges or are sub-networks hub genes. Three classifiers were used, namely Random Forest (RF), Diagonal Linear Discriminant Analysis and Support Vector Machines (SVM), with 5-fold cross validation. It concludes that including network information may lead to the identification of more stable gene expression signatures. (Dominietto et al., 2015) , shows how to integrate imaging data into networks to define tumor fingerprints, through both network topology and the detection of dynamic connectivity patterns.
In (Chuang et al., 2007) PPI subnetwork markers are found to distinguish between metastatic and nonmetastatic tumors, using a score function. Candidate subnetworks are built starting with a single protein and are expanded using the PPI network, until the score stops to increase. The activity scores calculated from the average of the expression levels of each subnetwork were used as feature values. The classifiers used were based on logistic regression and SVM using 5-fold cross validation. In (Chen and Yang, 2014) , normal, benign and malignant states of breast cancer are differentiated, building a gene regulatory network representative of each state and comparing their network topological properties (in and out-degree, betweenness, cluster coefficient and closeness). Gene ranking was made selecting 53 hub genes. (Wang et al., 2015) review describes pathway and network-based approaches applied to cancer biomarker discovery, in particular to the liver and hepatocellular carcinoma (HCC). In (Ou-Yang et al., 2014) dynamic PPI networks are constructed from time-course gene expression data and PPI data, extracting stable and dynamic interactions along time to predict temporal protein complexes. An approach. using differential co-expression analysis and PPI networks for study human HCC progression that uses subnetworks for each of the five stages of this carcinoma can be found in (Yu et al., 2013) .
Data mining classification techniques have been used to look for signatures in cancer diseases. A large number of variables can be used to characterize cancer and non-cancer biological datasets, so it is necessary to choose the most relevant. There are several feature selection algorithms and a review is presented in (Saeys et al., 2007) , including the ReliefF feature selection method (Kononenko, 1994) used in this paper. In (Nancy and alias Balamurugan, 2013), the ReliefF feature selection method is claimed to be the best method among several tested for cancer classification using gene expression data. Also ReliefF algorithm is efficient, and adequate when there is much feature interaction, ranking well the quality of features when there is a strong dependency between them (Robnik-Šikonja and Kononenko, 2003) .
In (Furey et al., 2000) , a score is calculated for the expression values of genes, to select those with highest scores as features in the classification withhold-one-out cross validation. Tests were made and the best results were obtained with 50 genes. (Ramani and Jacob, 2013 ) uses a Bayesian Network Learning (BNL) prediction to classify lung cancer tumors as Small Cell Lung Cancer (SCLC), NonSmall Cell Lung Cancer (NSCLC) and COMMON classes, using the structural and physicochemical properties of protein sequences obtained from genes using microarray analysis. Several feature selection methods were used with different prediction techniques. Best results were obtained using BNL with Gain Ratio. A model for predicting the survival rate of patients affected by lung cancer, applying different feature selection algorithms, can be found in (Dezfuly and Sajedi, 2015) . The classification algorithms used were: Decision Tree (DT), BNL and Neural Network (NN).
A new network-based supervised classification method to predict cancer, named NBC and using only gene expression levels is presented in (Ay et al., 2014) . It was applied to different datasets, (lung, breast, leukaemia and colon cancers) using five classification algorithms, namely SVM, KNN, NBL, C4.5 and RF with 10-fold cross validation and with five feature selection methods. A gene-association network was created for each class, where nodes are genes and edges represent the correlation between their expression levels. High accuracy classification was obtained with less than 100 genes.
METHODS
This paper describes a system-based approach to classify between cancer and non-cancer tissues and can contribute to find signatures that distinguish disease biological processes from healthy biological processes, using the topological properties of networks and considering the network topological dynamics embedded in the disease system.
A network-based method is used, by constructing a set of PPI networks, one for each sample belonging to the SSN. The ReliefF algorithm (Kononenko, 1994 ) is used to rank a subset of genes. In each SSN network, nodes are proteins coded by a subset of the most expressed genes of the top ReliefF genes and edges indicate that the proteins coded by those genes interact physically. A score was used as a threshold for the PPI interactions.
Network topological properties were used as features in the supervised binary classification methodology and their values were obtained from the topological analysis of each SSN network.
These classification models were evaluated using the statistical measures, accuracy, precision, recall, F1-score and area under the ROC curve.
Four datasets were used, three from breast cancer microarray experiments and one from a liver cancer microarray experiment. Three types of tests were made: using 5 fold cross-validation; using data obtained from two of the breast cancer datasets as train set, and data obtained from the other breast cancer dataset as test set; and using data obtained from the three breast cancer datasets to train the dataset and, for testing, using data obtained from the liver cancer dataset.
Gene Expression Microarray Data Sets
The experiments were obtained from ArrayExpress (Kononenko, 1994) , an algorithm that can be applied to continuous and discrete values. For each experiment the top ReliefF 100 genes were selected and merged in one matrix of 735 samples and 276 genes for breast cancer and one matrix of 124 samples and 276 genes for the liver cancer. The PPI SSN was obtained from the 100 most expressed genes from each sample of the previous matrixes. The number 100 genes belongs to the typical interval of 50 to 150 number of genes used for binary classifications studies (Ay et al., 2014) .
Protein-protein Interaction Networks
DAVID and UNIPROT were primarily used (Dennis et al., 2003 , Consortium, 2014 to obtain the mapping of identifiers from probeset ids and gene names to proteins. The human PPI dataset was obtained from STRING, an online database resource with several distinct types and sources of PPI information. Using this dataset, several networks were constructed, one for each sample, representing the entire set of PPI for all different samples. Only PPIs with score greater or equal to 300 were considered. These networks were constructed as undirected, unweight and with no selfedges.
Classification Methods
The set of supervised learning algorithms used were the KNN classifier, the SVM classifier implemented using an RBF kernel, and the RF, all with default parameters. Classification results were obtained using Orange through scripting in Python and through visual programming in Orange Canvas (Demsar et al., 2007) .
The statistical measures used to evaluate the performance of the binary classification models were, the classification accuracy (CA), the precision (Precision), the recall (Recall), the F1-score (F1) and the area under the ROC Curve (AUC) (Sokolova and Lapalme, 2009) , where TP (true positive) is the number of correctly predicted samples that belong to the class, TN (true negative) is the number of correctly predicted samples that do not belong to the class, FP (false positive) is the number of wrongly predicted samples that belong to the class and FN (false negative) is the number of wrongly predicted samples that do not belong to the class.
Accuracy (CA) calculates the proximity of measurement results to the true value and gives the global efficacy of a classifier.
Precision (Precision) specifies the positive labels given by the classifier that are correct.
Recall or sensitivity shows the efficacy of a classifier to identify positive labels.
Recall = TP/P = TP / (TP+FN).
F1-score (F1) is the harmonic mean of precision and recall and is between 0 and 1, being 1 the best value.
F1 = 2 x (Precision x Recall
Area under the ROC curve (AUC) is the classifier's capacity to avoid false classification.
AUC = 1/2 ((TP / (TP+FN)) + (TN / (FP + TN))
Three strategies were used, the first one with classification results obtained by 5 fold crossvalidation and the others two using a separate test data, one from the same type of cancer and the other from a different type of cancer. 
Network-based Approach
An undirected and unweighted graph G can be defined as a pair G = (V, E) where V is a set of vertices representing the nodes and E is a set of edges representing the connections between the nodes i and j. The number of nodes of a graph G is denoted by N and the number of edges of a graph is denoted by L.
Given a graph G = (V, E) the adjacency matrix representation consists of an N x N matrix A = [a ij ], such that a ij = 1 if (i, j) belongs to E or a ij = 0 otherwise. For undirected graphs the matrix is symmetric.
Descriptors obtained from the analysis of the SSN topologies were calculated using the package NetworkX from Python (Schult and Swart, 2008) , the R package QuACN (Mueller et al., 2011) and the gtrieScanner (Ribeiro and Silva, 2014) software.
The following methodology was used to obtain SSN network-based features (Figure 1 ):
Step 1: Obtain the e matrixes, for e=1,…, ne, where ne is the number of microarray experiments, ns e is the number of samples of the experiment e and ng is the number of genes.
EXP e = [exp ij ], i=1,…, ns e ; j=1, …, ng
Step 2: Obtain the lists of the top genes ranked by decreasing order of ReliefF LTGR e , for e=1,..., ne
Step 3: Obtain the union of the previous lists, for a threshold value, thr_rf that defines the number of top elements of the lists to be considered.
Step 4: Obtain the submatrices of EXP e , for e=1, ..., ne, obtained in step 1., for the genes selected in step 3. SEXP = [sexp ij ], for i=1,..., sum e (ns e ); j=1,…, thr_rf (9)
Step 5: Obtain the lists of the top thr_me most expressed genes in SEXP, for each sample from e experiments, for e=1,…, ne.
LGME= [lgme ij ], for i=1,..., sum e (ns e ); j=1, .., thr_me (10)
Step 6: Obtain the lists of the proteins encoded by the genes of the LGME matrix, P(LGME) for each sample of the experiments e, for e=1, ..., ne. LPME= P(LGME) i , for i=1,..., sum e (ns e ) (11) Step 7: Obtain the SSN, the PPI human interaction sub-networks induced by LPME. SSN= [ssn i ], for i=1,..., sum e (ns e ); e=1,…, ne Step 8: Calculate the five groups of topological properties for each ssn belonging to SSN, where the number of features, nf, is the number of descriptors used.
FEAT= [feat ij ], for i=1,…, sum e (ns e ); j=1,..., nf; e=1,..., ne
Several topological measures were included to capture the structural complexity of the biological networks. Hereafter are referred the five groups of descriptors used.
A first group of 15 descriptors, named D0, calculated using NetworkX (Table 1) . A second group of 16 descriptors, named D1 that uses distances between nodes to capture the structural complexity of the network, a third group, named D2, of 14 descriptors and a forth group of 6 more recent descriptors, named D3, all of them calculated using QuACN (Table 2) . A fifth group , named D4, of 58 descriptors, where the first 29 are corresponding to the relative frequency values of 3 to 5 nodes subgraphs if they are a motif and zero if they are not a motif and the last 29 are the correspondent z-score values, which were calculated using 1000 random networks (Table 3) . These descriptors were calculated using the gtriesScanner software. A motif is a subgraph that is frequent compared to their frequency in a set of similar random networks. In this paper a subgraph is considered a motif (Milo et al., 2002) , if the frequency of the subgraph in the network is superior to 4, the difference between the frequency in the network (f) and the average frequency in 1000 similar random networks (avgfr) is greater or equal to 0.10 of the average frequency in those random networks, and |z-score| > 2, where z-score = (f -avgfr) / sd, with sd as the standard deviation. To build the binary classification models three different supervised learning algorithms were used, namely the KNN, SVM with RBF kernel and RF classifiers, all with default parameters. All of the Table 4 : Statistical evaluation (CA, Precision, Recall, F1 and AUC) of the binary classification C -Cancer and H-Healthy for the cases C1, C2, C3 and C4 using the three classifiers KNN, SVM and RF, for all of the network-based features and for the group of network-based features D4 for the class C.
classifiers used gave similar results, with a slight advantage in some statistical measures for RF when using information from breast cancer datasets.
The statistical measures used to evaluate the performance of the binary classification models were the CA, the Precision, the Recall, the F1 and the AUC and values were obtained using three strategies, with different sets of features groups.
The first strategy, named Case 1 (C1), used 5 fold cross-validation on the network-based features values calculated from the three breast cancer microarray datasets.
The second strategy included two types of tests that were named Case 2 (C2) and Case 3 (C3) and here two of the breast cancer datasets were used to calculate network-based features values for the training dataset and the remaining one was used to calculate the network-based features values for the test dataset. In C2, the training set used E_GEOD-65194 and E-GEOD-54002 microarray datasets and the test set used E_GEOD-29044 dataset and in C3, the training set used E_GEOD-54002 and E-GEOD-29044 datasets and the test set used E_GEOD-65194 microarray dataset.
The third strategy, named Case 4 (C4), used data from the three breast cancer microarray datasets for the training dataset and the liver microarray dataset was used for the test dataset.
The two sets of features, whose results are shown in Table 4 , are the set of all of the network-based features (groups D0 to D4) and the set of networkbased features of the group D4. In the case C1, 5-fold cross validation was used, with results, above 0.95, for all the statistical measures considered. To test if the classification obtained in C1 was suffering from over fitting, different datasets were used as a train set and as test set, the cases C2 and C3. The results obtained were, for example for CA, above 0.80 for C2 and above 0.92 for C3, which evidence good performance of the classifier. The difference between the values of C2 and C3 may be explained by the imbalance between cancer and non-cancer samples.
To check if the classification models with datasets of one type of cancer can be generalized for another cancer type, the classification model was trained with data from three breast cancer datasets and tested with data obtained from a liver cancer dataset, in case C4. Values obtained and shown in Table 4 are still positive, probably due to the fact of all being cancer diseases, but worse than the previous ones.
To analyse which of the network-based features contributed more for the classification model a ranking list of features was done. Table 5 shows the top 5 ranking of the network-based features.
From the analysis of which features are more informative, it can be stated that the most relevant features belong mainly to group D0 and group D4. When all groups of topological features are used as features variables, it can be seen that the size of the largest clique and the number of nodes are better ranked. Motifs of size 4 and 5 are the most informative motifs. 
CONCLUSIONS
The statistical evaluation results were obtained using only topological properties as features variables, This new methodology of creating SSN allows the capture of the topology dynamics of the system through the set of samples and allows data to be reduced and be computationally manageable, keeping the more informative data, which is supported by the good results obtained. We consider that this novel approach is worth and gives different contributions compared to previous works, namely: the number of considered topological properties is much higher; the exclusive use of topological properties (global and local) with good binary classification results obtained; the topological dynamics of the system captured through each sample, different from other works that use time or states for example, which can contribute to the capture of different signatures.
The results obtained show that classification models should be different according to the cancer disease type considered. More, the knowledge of which features are more informative can be used, in the future, to look for signatures based in these features that could help in the identification of certain cancer types. Two of the most discriminative features obtained were the size of the largest clique and motifs of size 4 and 5. Cliques being fully connected subnetworks where genes are functionally related and highly expressed were considered by some researchers as gene signatures (Pradhan et al., 2012) . The relative frequency and z-score of some motifs as local topological properties measures, showed to be discriminatory features, indicating that there are clues that some small subnetworks could help to distinguish cancer samples. Adding more biological information to the more discriminative features found in the classification, may reveal important signatures like subgraphs markers of cancer diseases. This approach also seems worth to be further explored.
Finally the proposed methodology for creating SSN is a novel contribution that can be extended to other types of networks, besides PPIs, adding information that can differentiate samples and capture their topological dynamics helping to uncover new signatures that can be biologically relevant for the identification of diseases.
